Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Walgreens Boots Alliance, Inc. - Common Stock (NQ:WBA)

11.53 +0.01 (+0.09%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Walgreens Boots Alliance, Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
84 85 Next >
Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Walgreens Boots Alliance Outlines Three-Cost Saving Strategy As Q4 Earnings Beat Street Estimates
Walgreens Boots Alliance reported Q4 FY2024 sales of $37.55B, a 6% increase year-over-year, with pharmacy sales up 9.6%. Adjusted EPS was $0.39, beating analyst expectations. Key growth seen in U.S.... 
Via Benzinga
Topics Earnings
Big Potential Brewing – Will Walgreens Deliver a Rally?
Walgreens stock could go on a double-digit rally this week on earnings, at least that's what options traders are betting on, even Wall Street thinks so 
Via MarketBeat
CVS Health: Are Its Parts Worth More Than the Whole?
CVS Health Co. (NYSE: CVS) transformed from one of the largest drug store pharmacy chains in the country to an integrated healthcare company 
Via MarketBeat
Earnings Preview For Walgreens Boots Alliance
Via Benzinga
Navigating 5 Analyst Ratings For Walgreens Boots Alliance
Via Benzinga
Walgreens Stock Jumps As Ailing Drug Store Giant Plans To Cut 1,200 Locations
Walgreens topped Q4 EPS views and plans to cut 1,200 drug store locations. 
Via Investor's Business Daily
Walgreens Boots Alliance Reports Fiscal Year 2024 Earnings
From Walgreens Boots Alliance
Via Business Wire
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
Wall Street mood has become circumspect as traders gear up to receive a slew of earnings reports this week amid the market’s record run. The Nasdaq Composite has been a laggard among the major averages... 
Via Benzinga
Topics Stocks
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd
Via AB Newswire
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd 
Via News Direct
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
The stock market has been on a two-year strong run and the extended rally has begun to stir valuation concerns. 
Via Benzinga
Walgreens Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Citigroup, Bank of America And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
The Boulder Group Arranges Sale of Net Leased Fast Pace Health Property in Tennessee
Via AB Newswire
Major Indexes Finish Higher As Earnings Season Sets In
Upbeat post-earnings sentiment sent the Dow and S&P 500 to fresh record highs, with big banks among those making major moves, as well as a myriad of blue-chip leaders. 
Via Talk Markets
Topics Stocks
The Bull's Biggest Hits And Misses
The bull market turned two years old over the weekend. Here are some of the S&P 500's biggest winners and losers over the last two years. 
Via Talk Markets
Topics Stocks
Large-Cap Stocks In Trouble - Sunday, Oct. 13
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Walgreens: A New Risk Just Emerged for the Stock
Can this pharmacy retailer overcome this latest threat? 
Via The Motley Fool
Troubled Victoria’s Secret stock could surge by 72%
Victoria’s Secret (VSCO) stock has stabilized in the past few weeks as investors focus on the recent leadership transition and the ongoing turnaround. 
Via Talk Markets
Where Does Hims & Hers Stock Go From Here?
Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright? 
Via The Motley Fool
Palo Alto Networks To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026,... 
Via Benzinga
Walgreens Boots Alliance vs. Altria Group: What's the Better Dividend Stock to Own?
These stocks offer a lot of dividend income, but are they worth the risk? 
Via The Motley Fool
2 Ultra-High-Yield Dividend Stocks Are Near 52-Week Lows. Is It Time to Buy the Dips?
With yields of 8% or better at recent prices, these dividend payers are hard to ignore. 
Via The Motley Fool
Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer
From Walgreens
Via Business Wire
Celly Nutrition Signs a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America.
Vancouver, British Columbia--(Newsfile Corp. - October 7, 2024) - Celly Nutrition Corp. ("Celly Nu" or the "Company"), led by CEO... 
Via Newsfile
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Walgreens Boots Alliance, Inc. (WBA)
From Glancy Prongay & Murray LLP
Via Business Wire
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
Via Benzinga
Hanley Investment Group Arranges Sale of Single-Tenant Walgreens at Kroger-Anchored Shopping Center in Houston Metro
Via AB Newswire
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
84 85 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.